Moreover, NF1 appears amplified in almost 17% of a special type of breast cancer, i.e., adenoid cystic breast carcinoma [30], and in a significant minority of other specific cancers, including biliary tract, gastric, bladder urothelial, and pancreatic cancers. Here, NF1 is linked to cancer.